Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 2,487 | 0.0% | 17,534 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 1,997 | 0.0% | 14,224 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,957 | 0.0% | 15,568 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 2,142 | 0.0% | 19,363 | 3/31/2025 |
| 2024 Q4 | 2/18/2025 | 2,638 | 0.0% | 19,329 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,934 | 0.0% | 16,786 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,623 | 0.0% | 19,056 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 1,618 | 0.0% | 11,730 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 1,480 | 0.0% | 11,233 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 989 | 0.0% | 8,789 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 829 | 0.0% | 8,789 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 866 | 0.0% | 8,559 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 1,005 | 0.0% | 8,415 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 991 | 0.0% | 9,334 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 1,069 | 0.0% | 10,967 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 1,373 | 0.0% | 14,645 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 1,414 | 0.0% | 16,600 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,677 | 0.0% | 17,487 | 9/30/2021 |
| 2021 Q2 | 9/29/2021 | 1,689 | 0.0% | 17,351 | 6/30/2021 |
| 2021 Q1 | 4/30/2021 | 1,413 | 0.0% | 14,531 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 1,434 | 0.0% | 14,966 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 1,471 | 0.0% | 15,301 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 1,714 | 0.0% | 14,050 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 828 | 0.0% | 9,571 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 2,204 | 0.0% | 20,501 | 12/31/2019 |